Qihuang Jianpi Zishen Granules ameliorate renal damage in MRL/lpr mice by inhibiting the MyD88/NF-κB pathway.
10.12122/j.issn.1673-4254.2025.08.07
- Author:
Zhongfu TANG
1
;
Chuanbing HUANG
1
;
Ming LI
1
;
Lili CHENG
1
;
Junjie CHEN
1
;
Shuangshuang SHANG
1
;
Sidi LIU
1
Author Information
1. First Affiliated Hospital of Anhui University of Chinese Medicine.
- Publication Type:Journal Article
- Keywords:
MRL/lpr mice;
MyD88/NF‑κB pathway;
Qihuang Jianpi Zishen Granules;
renal damage;
systemic lupus erythematosus
- MeSH:
Animals;
Drugs, Chinese Herbal/therapeutic use*;
Female;
Mice, Inbred C57BL;
Mice, Inbred MRL lpr;
Myeloid Differentiation Factor 88/metabolism*;
Mice;
NF-kappa B/metabolism*;
Signal Transduction/drug effects*;
Kidney/metabolism*;
Interleukin-17
- From:
Journal of Southern Medical University
2025;45(8):1625-1632
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the mechanism of Qihuang Jianpi Zishen Granules (QJZ) for ameliorating renal damage in MRL/lpr mice.
METHODS:With 6 female C57BL/6 mice as the normal control group, 30 female MRL/lpr mice were randomized into model group, QJZ treatment groups at low, moderate and high doses, and prednisone treatment group (n=6). After 8 weeks of treatment, the mice were examined for 24-h urine protein, creatinine and albumin levels, serum levels of IgG, complement 3 (C3), C4, anti-dsDNA, interferon γ (IFN‑γ) and interleukin 17 (IL-17). Kidney tissues were sampled for histopathological examination with HE staining and observation of glomerular ultrastructure changes using transmission electron microscopy (TEM). The expressions of MyD88/NF-κB pathway-related molecules in the kidney tissue were detected using RT-qPCR, Western blotting and immunohistochemistry.
RESULTS:Compared with those in the model group, the mice treated with QJZ at the 3 doses and prednisone showed significant reductions in the renal injury biomarkers and serum IgG, anti-dsDNA, IFN‑γ and IL-17 levels and elevation of serum C3 and C4 levels. HE staining revealed lessened glomerular endothelial cell proliferation and mesangial thickening in all the treatment groups. TEM observation further demonstrated reduced electron-dense deposits and diminished inflammatory cell infiltration in the glomeruli in the intervention groups. QJZ at the 3 doses and prednisone treatment all significantly lowered renal expression levels of MyD88, NF-κB, p65 and p52 in the mouse models.
CONCLUSIONS:QJZ can improve renal damage in MRL/lpr mice possibly by inhibiting overactivation of the MyD88/NF-κB pathway.
